Turkey While supporters of Turkey’s localization policy for pharmaceuticals implemented in 2016 applaud the changes it has brought, its opponents are awaiting a much-anticipated report by the World Trade Organization that could put an end to the policy and have global repercussions. Five years after the launch of Turkey’s localization…
China Shirley Xu, president of Baxter Greater China, reflects on her extraordinary 26-year (and counting) career with Baxter China, including her perspectives on the success factors behind Baxter’s growth in the country over the past decades, its strengths as a diversified healthcare company offering not only pharmaceutical products but medical devices…
Turkey In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce Turkey’s reliance on imports – a few years later, it has created a young, ambitious export sector. Turkey’s experiment with mandatory localisation policies for pharmaceutical and medical products production is paying off nicely.…
Pharma Long renowned for dancing to a different tune, Italy’s eccentric, but more often than not, enlightened and high performance pharma, healthcare and life sciences community may at last be about to reign in a distinctive penchant for fragmentation. Amongst the myriad of globally recognized luxury brands promulgated by the Italian…
Pharma The President and MD of Abiogen Pharma discusses his family company’s recent milestones, the reasons for persisting with local manufacturing, and the benefits of international partnerships. You created Abiogen back in 1997, following the acquisition of Istituto Gentili by MSD, in order to maintain your family’s entrepreneurial tradition and build…
Algeria
locals Tuğçe Koç describes the company’s initial aspirations in targeting the higher value-added therapeutic area of oncology and the type of market opportunities that are present domestically and internationally. With over 25 years of experience, Onko Koçsel has established a strong foothold in the Turkish pharmaceutical industry—first with the introduction of…
locals The co-founder of Ekin Kimya discusses the need for greater regulation and monitoring of raw materials used in Turkish pharmaceutical manufacturing, his company’s key role as an educator and advisor to the industry with regards to international regulatory standards, and unique role as a supplier that provides robust support services,…
locals The chairman and CEO of Santa Farma discusses how the Turkish pharmaceutical landscape has evolved in response to the government’s healthcare transformation programs. He also enumerates various strategic initiatives the company is pursuing to bolster its competitive positioning the market such as constructing new state-of-the-art production and R&D facilities, penetrating…
hospitals The managing director at Adcock Ingram Critical Care reveals the company’s unique business model. As a long-established division within Adcock Ingram, Critical Care operates with relative independence. What is the relationship between Critical Care and the group? We had historical group strategy focused on a centralized business model, with one of…
manufacturing One of the directors of Romania’s number one producer of suppositories and the only in-country manufacturer of contraceptive ovules speaks out about how the country is fast becoming a regional manufacturing hub and preferred destination for final batch customisation. He also talks extensively about the state of GMP in the country. Magistra…
locals The CEO of Centurion shares his ambitious vision for the company’s expansion into plasma products, biotech, orphan drugs, and generic injectables over the coming years, while simultaneously developing sales in more than twenty countries across the EU, CIS, GCC and MENA regions. As a company working on bringing biotech production to Turkey,…
See our Cookie Privacy Policy Here